Immunogenicity and reactogenicity after heterologous prime-boost vaccination with CoronaVac and ChAdox1 nCov-19 (AZD1222) vaccines-Reference-Cited by-同舟云学术

Immunogenicity and reactogenicity after heterologous prime-boost vaccination with CoronaVac and ChAdox1 nCov-19 (AZD1222) vaccines

Published:2022-03-24 Issue:5 Volume:18 Page:
ISSN:2164-5515
Container-title:Human Vaccines & Immunotherapeutics
language:en
Short-container-title:Human Vaccines & Immunotherapeutics

Author:

Cohen Guy¹,Jungsomsri Pawornrath¹,Sangwongwanich Jirath¹,Tawinprai Kriangkrai²^ORCID,Siripongboonsitti Taweegrit²,Porntharukchareon Thachanun²,Wittayasak Kasiruck³,Thonwirak Nawarat³,Soonklang Kamonwan³,Sornsamdang Gaidganok⁴,Auewarakul Chirayu³⁵,Mahanonda Nithi²

Affiliation:

1. Department of General Practice and Family Medicine, Chulabhorn Hospital, Chulabhorn Royal Academy, Bangkok, Thailand

2. Department of Medicine, Chulabhorn Hospital, Chulabhorn Royal Academy, Bangkok, Thailand

3. Center of Learning and Research in Celebration of HRH Princess Chulabhorn’s 60th Birthday Anniversary, Chulabhorn Royal Academy, Bangkok, Thailand

4. Central Laboratory Center, Chulabhorn Hospital, Chulabhorn Royal Academy, Bangkok, Thailand

5. Princess Srisavangavadhana College of Medicine, Chulabhorn Royal Academy, Bangkok, Thailand

Funder

Chulabhorn Royal Academy

National Vaccine Institute, Thailand

Publisher

Informa UK Limited

Subject

Pharmacology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/21645515.2022.2052525

Reference39 articles.

1. An interactive web-based dashboard to track COVID-19 in real time

2. WHO. Status of COVID-19 vaccines within WHO EUL/PQ evaluation process. 2021 [accessed 2021 Oct 16].

3. COVID-19 WHO Thailand Situation Reports. [accessed 2021 Oct 16]. https://cdn.who.int/media/docs/default-source/searo/thailand/2021_10_14_tha-sitrep-205-covid-19.pdf?sfvrsn=8ba57507_3

4. Effectiveness of an Inactivated SARS-CoV-2 Vaccine in Chile

5. Effect of 2 Inactivated SARS-CoV-2 Vaccines on Symptomatic COVID-19 Infection in Adults

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Heterologous Prime-Boost Immunization Strategies Using Varicella-Zoster Virus gE mRNA Vaccine and Adjuvanted Protein Subunit Vaccine Triggered Superior Cell Immune Response in Middle-Aged Mice;International Journal of Nanomedicine;2024-08

2. Top 100 cited research on COVID-19 vaccines: A bibliometric analysis and evidence mapping;Human Vaccines & Immunotherapeutics;2024-07-08

3. Safety and immunogenicity of CoronaVac and ChAdOx1 heterologous prime-boost vaccines in an overweight population in Chiang Mai, Thailand;Vaccine: X;2024-06

4. Study of efficacy and antibody duration to fourth-dose booster of Ad5-nCoV or inactivated SARS-CoV-2 vaccine in Chinese adults: a prospective cohort study;Frontiers in Immunology;2023-09-06

5. Neutralizing antibody and T-cell responses against SARS-CoV-2 variants by heterologous CoronaVac/ChAdOx-1 vaccination in elderly subjects with chronic obstructive pulmonary disease;Vaccine;2023-09